Research progress on the role of miRNA in nasopharyngeal carcinoma

doi:10.3760/cma.j.issn.1007-1245.2022.08.032

Abstract

Abstract: Nasopharyngeal carcinoma is one of the common malignant tumors in China. Its incidence location is hidden and it is not easy to find in the early clinical stage, most of them are already in the middle and late stage when found out. MicroRNA (miRNA) is an endogenous, non-coding single-stranded RNA molecule about 22 nucleotides long. MiRNA can target the expression of a variety of tumor-related genes. With the in-depth research on miRNA at home and abroad, tumor-specific miRNA has become a new target for the treatment of nasopharyngeal carcinoma and a biomarker for prognosis prediction. In this review, the role of miRNA in the pathogenesis, development, diagnosis, treatment, prognosis prediction, and radiotherapy resistance of nasopharyngeal carcinoma was reviewed.

Key words: Nasopharyngeal carcinoma, MiRNA, Review

摘要： 鼻咽癌是中国常见的恶性肿瘤之一，其发病位置隐蔽且在早期临床不容易发现，发现时大多数已经是中晚期。微小核糖核酸（miRNA）是一段长约为22个核苷酸的内源性非编码单链RNA分子。miRNA可以靶向调控多种肿瘤相关基因的表达。随着国内外对miRNA深入研究，肿瘤特异性miRNA成为治疗鼻咽癌的新靶点和预测预后的生物标志物。本文主要从分子生物学特性来综述miRNA在鼻咽癌发生、发展、诊治和预后评估、放疗耐药中的研究现状。

关键词: 鼻咽癌, miRNA, 综述

Li Shihua, Zhou Hui, Yao Jun. Research progress on the role of miRNA in nasopharyngeal carcinoma[J]. International Medicine and Health Guidance News, 2022, 28(8): 1168-1171.

李诗华, 周慧, 姚俊. miRNA在鼻咽癌中的研究进展[J]. 国际医药卫生导报, 2022, 28(8): 1168-1171.

References

[1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.

[2] Sun X, Su S, Chen C, et al. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities[J]. Radiother Oncol, 2014, 110(3): 398-403. DOI: 10.1016/j.radonc.2013.10.020.

[3] 周世平,张哲. miRNA与鼻咽癌侵袭转移关系的研究进展[J]. 中国耳鼻咽喉颅底外科杂志,2013,19(6):568-572. DOI:10.11798/j.issn.1007-1520.201306028.

[4] 王婷. miRNA在鼻咽癌中的研究进展[J]. 中国肿瘤,2012,21(7):519-524.

[5] Zhuo X, Zhou W, Li D, et al. Plasma microRNA expression signature involving miR-548q, miR-630 and miR-940 as biomarkers for nasopharyngeal carcinoma detection[J]. Cancer Biomark, 2018, 23(4): 579-587. DOI: 10.3233/CBM-181852.

[6] Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer[J]. Annu Rev Pathol, 2014, 9:287-314. DOI: 10.1146/annurev-pathol-012513-104715.

[7] Norouzi M, Yasamineh S, Montazeri M, et al. Recent advances on nanomaterials-based fluorimetric approaches for microRNAs detection[J]. Mater Sci Eng C Mater Biol Appl, 2019, 104:110007. DOI: 10.1016/j.msec. 2019.110007.

[8] Wang H, Wei X, Wu B, et al. Tumor-educated platelet miR-34c-3p and miR-18a-5p as potential liquid biopsy biomarkers for nasopharyngeal carcinoma diagnosis[J]. Cancer Manag Res, 2019, 11:3351-3360. DOI: 10.2147/CMAR.S195654.

[9] 黄刚,吴剑威. 微小RNA在鼻咽癌诊断和评估预后中的价值研究进展[J]. 现代医药卫生,2020,36(15):2398-2401. DOI:10.3969/j.issn.1009-5519.2020.15.028.

[10] 李晓霞,李瑞平,杜紫明,等. 鼻咽癌差异表达miRNAs筛选研究[J]. 中山大学学报(医学科学版),2007,28(6):607-612. DOI:10.3321/j.issn:1672-3554.2007.06.002.

[11] Sengupta S, den Boon JA, Chen IH, et al. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins[J]. Proc Natl Acad Sci U S A, 2008, 105(15): 5874-5878. DOI: 10.1073/pnas.0801130105.

[12] Hui AB, Bruce JP, Alajez NM, et al. Significance of dysregulated metadherin and microRNA-375 in head and neck cancer[J]. Clin Cancer Res, 2011, 17(24):7539-7550. DOI: 10.1158/1078-0432.CCR-11-2102.

[13] 肖烈钢,黄季萌,何本夫,等. miR-4295靶向结合PTEN促进EMT和鼻咽癌细胞的侵袭[J]. 国际医药卫生导报,2018,24(19):2934-2940. DOI:10.3760/cma.j.issn.1007-1245. 2018.19.015.

[14] Shi Q, Dai J, Huang L. microRNA-29a functions as a tumor suppressor in nasopharyngeal carcinoma 5-8F cells through targeting VEGF[J]. Iran J Basic Med Sci, 2019, 22(5): 541-546. DOI: 10.22038/ijbms.2019.33818.8049.

[15] Gao R, Feng Q, Tan G. microRNA-613 exerts anti-angiogenic effect on nasopharyngeal carcinoma cells through inactivating the AKT signaling pathway by down-regulating FN1[J]. Biosci Rep, 2019, 39(7):BSR20182196. DOI: 10.1042/BSR20182196.

[16] Cui F, Ji Y, Wang M, et al. miR-143 inhibits proliferation and metastasis of nasopharyngeal carcinoma cells via targeting FMNL1 based on clinical and radiologic findings[J]. J Cell Biochem, 2019, 120(10):16427-16434. DOI: 10.1002/jcb.28709.

[17] Liang TS, Zheng YJ, Wang J, et al. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2[J]. J Exp Clin Cancer Res, 2019, 38(1):97. DOI: 10.1186/s13046-019- 1023-4.

[18] Sun X, Liu X, Wang Y, et al. miR-100 inhibits the migration and invasion of nasopharyngeal carcinoma by targeting IGF1R[J]. Oncol Lett, 2018, 15(6):8333-8338. DOI: 10.3892/ol.2018.8420.

[19] Calin GA, Ferracin M, Cimmino A, et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia[J]. N Engl J Med, 2005, 353(17): 1793-1801. DOI: 10.1056/NEJMoa050995.

[20] Zheng Z, Qu JQ, Yi HM, et al. MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway[J]. Cell Death Dis, 2017, 8(6): e2855. DOI: 10.1038/cddis.2017.211.

[21] 王蔓菁,刘丽娟,周芳,等. 鼻咽癌与miRNAs[J]. 现代生物医学进展,2011,11(13):2565-2567.

[22] Ye SB, Zhang H, Cai TT, et al. Exosomal miR-24-3p impedes T-cell function by targeting FGF11 and serves as a potential prognostic biomarker for nasopharyngeal carcinoma[J]. J Pathol, 2016, 240(3): 329-340. DOI: 10.1002/path.4781.

[23] Wang F, Lu J, Peng X, et al. Integrated analysis of microRNA regulatory network in nasopharyngeal carcinoma with deep sequencing[J]. J Exp Clin Cancer Res, 2016, 35:17. DOI: 10.1186/s13046-016-0292-4.

[24] 倪雅楠,季明芳. EBV miR-BARTs在鼻咽癌中的研究及应用进展[J]. 肿瘤学杂志,2020,26(4):269-274. DOI:10.11735/j.issn.1671-170X.2020.04.B001.

[25] 李璐,王建红,黄辉,等. 鼻咽癌血清miRNA表达谱分析[J]. 华夏医学,2014,27(6):1-4.

[26] Tian Y, Tang L, Yi P, et al. MiRNAs in radiotherapy resistance of nasopharyngeal carcinoma[J]. J Cancer, 2020, 11(13): 3976-3985. DOI: 10.7150/jca.42734.

[27] Wan FZ, Chen KH, Sun YC, et al. Exosomes overexpressing miR-34c inhibit malignant behavior and reverse the radioresistance of nasopharyngeal carcinoma[J]. J Transl Med, 2020,18(1): 12. DOI: 10.1186/s12967-019-02203-z.

[28] Huang T, Yin L, Wu J, et al. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis[J]. J Exp Clin Cancer Res, 2016, 35(1): 188. DOI: 10.1186/s13046-016-0465-1.

[29] Zhang T, Sun Q, Liu T, et al. MiR-451 increases radiosensitivity of nasopharyngeal carcinoma cells by targeting ras-related protein 14 (RAB14) [J]. Tumour Biol, 2014, 35(12):12593-12599. DOI: 10.1007/s13277-014- 2581-x.